A long-standing belief about HIV has quietly shaped how scientists think about the virus. For decades, researchers described ...
3don MSNOpinion
Hiltzik: This pharma company makes a miracle HIV drug, but is blocking access for millions of low-income people
Gilead's lenacapavir could transform the fight against HIV — but only if millions more patients can get it.
Timely HIV diagnosis and treatment are critical to preventing transmission. To help make this happen, the U.S. Centers for ...
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results